These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phytosphingosine stimulates the differentiation of human keratinocytes and inhibits TPA-induced inflammatory epidermal hyperplasia in hairless mouse skin. Kim S; Hong I; Hwang JS; Choi JK; Rho HS; Kim DH; Chang I; Lee SH; Lee MO; Hwang JS Mol Med; 2006; 12(1-3):17-24. PubMed ID: 16838068 [TBL] [Abstract][Full Text] [Related]
3. Staurosporine induces protein kinase C agonist effects and maturation of normal and neoplastic mouse keratinocytes in vitro. Dlugosz AA; Yuspa SH Cancer Res; 1991 Sep; 51(17):4677-84. PubMed ID: 1678684 [TBL] [Abstract][Full Text] [Related]
4. Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation. Yamamoto S; Kiyoto I; Aizu E; Nakadate T; Hosoda Y; Kato R Carcinogenesis; 1989 Jul; 10(7):1315-22. PubMed ID: 2544313 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C-alpha coordinately regulates cytosolic phospholipase A(2) activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes. Wang HQ; Kim MP; Tiano HF; Langenbach R; Smart RC Mol Pharmacol; 2001 Apr; 59(4):860-6. PubMed ID: 11259631 [TBL] [Abstract][Full Text] [Related]
6. Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis. Gupta AK; Fisher GJ; Elder JT; Talwar HS; Esmann J; Duell EA; Nickoloff BJ; Voorhees JJ J Invest Dermatol; 1989 Sep; 93(3):379-86. PubMed ID: 2570112 [TBL] [Abstract][Full Text] [Related]
7. Sustained phospholipase D activation is associated with keratinocyte differentiation. Jung EM; Betancourt-Calle S; Mann-Blakeney R; Griner RD; Bollinger Bollag W Carcinogenesis; 1999 Apr; 20(4):569-76. PubMed ID: 10223183 [TBL] [Abstract][Full Text] [Related]
8. Cyclosporin A inhibits 12-O-tetradecanoyl-phorbol-13-acetate-induced cutaneous inflammation in severe combined immunodeficient mice that lack functional lymphocytes. Reynolds NJ; Voorhees JJ; Fisher GJ Br J Dermatol; 1998 Jul; 139(1):16-22. PubMed ID: 9764143 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse skin ornithine decarboxylase and protein kinase C by polyphenolics from grapes. Bomser J; Singletary K; Meline B Chem Biol Interact; 2000 Jun; 127(1):45-59. PubMed ID: 10903418 [TBL] [Abstract][Full Text] [Related]
10. Activation of epidermal akt by diverse mouse skin tumor promoters. Lu J; Rho O; Wilker E; Beltran L; Digiovanni J Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992 [TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Lu YP; Chang RL; Lou YR; Huang MT; Newmark HL; Reuhl KR; Conney AH Carcinogenesis; 1994 Oct; 15(10):2363-70. PubMed ID: 7955078 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase C regulates keratinocyte transglutaminase (TGK) gene expression in cultured primary mouse epidermal keratinocytes induced to terminally differentiate by calcium. Długosz AA; Yuspa SH J Invest Dermatol; 1994 Apr; 102(4):409-14. PubMed ID: 7908680 [TBL] [Abstract][Full Text] [Related]
13. Differential down-regulation of epidermal protein kinase C by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol: association with epidermal hyperplasia and tumor promotion. Hansen LA; Monteiro-Riviere NA; Smart RC Cancer Res; 1990 Sep; 50(18):5740-5. PubMed ID: 2393848 [TBL] [Abstract][Full Text] [Related]
14. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells. Luo W; Sharif TR; Houghton PJ; Sharif M Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245 [TBL] [Abstract][Full Text] [Related]
15. Protein kinase C-dependent and -independent actions of a potent protein kinase C inhibitor, staurosporine. Yamamoto S; Jiang H; Nishikawa K; Ishihara M; Wang JC; Kato R Eur J Pharmacol; 1992 Oct; 227(2):113-22. PubMed ID: 1426027 [TBL] [Abstract][Full Text] [Related]
16. Protein kinase C agonist and antagonist effects in normal human epidermal keratinocytes. Matsui MS; Illarda I; Wang N; DeLeo VA Exp Dermatol; 1993 Dec; 2(6):247-56. PubMed ID: 8162345 [TBL] [Abstract][Full Text] [Related]
17. A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation. Palazzo E; Kellett MD; Cataisson C; Bible PW; Bhattacharya S; Sun HW; Gormley AC; Yuspa SH; Morasso MI Cell Death Differ; 2017 Apr; 24(4):717-730. PubMed ID: 28186503 [TBL] [Abstract][Full Text] [Related]
18. Staurosporine, a potent protein kinase C inhibitor, augments phorbol ester-caused ornithine decarboxylase induction in mouse epidermis. Jiang H; Yamamoto S; Kato R Carcinogenesis; 1992 Mar; 13(3):355-9. PubMed ID: 1547524 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of phorbol ester-caused induction of ornithine decarboxylase and tumor promotion in mouse skin by staurosporine, a potent inhibitor of protein kinase C. Yamada S; Hirota K; Chida K; Kuroki T Biochem Biophys Res Commun; 1988 Nov; 157(1):9-15. PubMed ID: 3196353 [TBL] [Abstract][Full Text] [Related]
20. Cutaneous changes during prolonged application of 12-O-tetradecanoylphorbol-13-acetate on mouse skin and residual effects after cessation of treatment. Aldaz CM; Conti CJ; Gimenez IB; Slaga TJ; Klein-Szanto AJ Cancer Res; 1985 Jun; 45(6):2753-9. PubMed ID: 3986807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]